Quite interesting to see that the incidence of re revascularisation after multivessel PCA ( the additional element on the second co-primary outcome) appears to have occured in more than 1% of the patients within 3 years...
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Congestive Heart Failure
July 30, 2019
U.S. News has just released the 2019-2020 best hospitals in the United States based on data from nearly 5,000 medical centers.
April 23, 2019
This video demonstrates the right subclavian artery cut-down technique for implantation of an Impella® 5.0 as a short-term mechanical circulatory support device for the left heart.
Surgery for Chronic Thromboembolic Pulmonary Hypertension: Thromboendarterectomy of the Pulmonary Artery
February 27, 2019
The authors discuss diagnosis of and surgery for chronic thromboembolic pulmonary hypertension in a severely symptomatic patient.
Third Annual Pediatric Interagency Registry for Mechanical Circulatory Support (PEDIMACS) Report: Pre-Implant Characteristics and Outcomes
February 26, 2019
Today, The Society of Thoracic Surgeons published the third annual Pediatric Interagency Registry for Mechanical Circulatory Support (PEDIMACS) report. Between Sep 19, 2012 and Dec 31, 2017, 423 patients (less than 19 years of age) in 30 hospitals were supported with 508 devices.
February 5, 2019
In a letter to healthcare providers, the US FDA summarized a recent evaluation of a postapproval study of the Abiomed Impella RP system. In clinical trials, 73% of patients survived 30 days after device explant, hospital discharge, or to definitive intervention. In the postapproval study, just over 17% of patients met this goal.
“Respect When You Can, Resect When You Should”: A Realistic Approach to Posterior Leaflet Mitral Valve Repair
December 6, 2018
Gilles Dreyfus and colleagues share a decade of mitral reconstruction for degenerative posterior leaflet pathology in Harefield and Monaco (38 per year was the formidable average). The supplementary video is of particular educational value for the mitral surgeon and the cardiologist/TOE (TEE) specialist.
October 23, 2018
This video demonstrates a valve replacement surgery for a 55-year-old woman who presented with carcinoid heart disease caused by a primary ovarian carcinoid tumor.
October 9, 2018
The authors demonstrate a successful pulmonary thromboendarterectomy, performed for a 37-year-old woman with chronic thromboembolic pulmonary hypertension.
September 25, 2018
This multicenter study evaluated the efficacy of medical therapy plus transcatheter valve repair (MitraClip) to medical therapy alone for heart failure accompanied by secondary moderate to severe mitral regurgitation. The device group experienced significantly fewer hospitalizations and lower mortality at 24 months follow-up.